Indo Borax & Chemicals Ltd-$ — earnings calls
2 quarters summarised from transcripts filed with the exchange, every statement cited. Newest first.
Indo Borax & Chemicals reported Q1 FY27 operating revenue of Rs. 70.36 crore, up 31.34% year-on-year, with EBITDA margin of 28.1% and net profit up 59.31% to Rs. 16.25 crore. Management attributed the growth to improved realizations, better capacity utilization, and the new leadership team installed after the ownership change to Zenrock Chemicals. The company also discussed its planned acquisition of 64.26% equity in Kronox Lab Sciences and outlined funding, integration and capacity expansion plans for both entities.
Indo Borax reported Q4 FY26 operating revenue of Rs. 63.01 crores, up 25.70% year-on-year, with net profit rising 41.9% to Rs. 14.53 crores. For full-year FY26, operating revenue grew 23% to Rs. 215.45 crores while EBITDA stayed roughly flat versus FY25 due to higher raw material costs. Management, under a new ownership structure led by Zenrock Chemicals, discussed capacity utilisation, product mix, a one-time special dividend from sale of non-core assets, and plans for new products and capacity expansion.